Form 4: Criteo CLO Ryan Damon Granted 63,259 Shares

Criteo's Chief Legal Officer, Ryan Damon, was granted 63,259 ordinary shares, subject to a multi-year vesting schedule and a potential contingency related to company conversion.

Summary

• Ryan Damon, Chief Legal Officer of Criteo S.A., was granted 63,259 ordinary shares on March 13, 2026.
• The shares were acquired at a price of $0, indicating a grant rather than a purchase.
• Following this transaction, Damon beneficially owns 177,154 ordinary shares.
• The shares are subject to time-based vesting: 25% will vest on the one-year anniversary of the grant date, with the remainder vesting in equal quarterly portions over the subsequent 36 months.
• A contingency exists: if Criteo's conversion into a Luxembourg company is not completed before the first anniversary of the grant date, 50% of the shares will vest on the two-year anniversary, and the remainder will vest quarterly over the subsequent two-year period.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive event, reflecting standard executive compensation practices that align management incentives with shareholder interests, without indicating any significant operational or strategic shifts.

Positives

• The equity grant aligns the Chief Legal Officer's interests with long-term shareholder value.
• The vesting schedule acts as a retention incentive for key management personnel.

Negatives

• The shares are restricted and subject to a multi-year vesting schedule, meaning no immediate liquidity for the officer.
• The vesting schedule includes a contingency related to the company's conversion to a Luxembourg entity, introducing a variable element.

Risks

• The vesting of a portion of the shares is contingent on the completion of Criteo's conversion into a Luxembourg company before the first anniversary of the grant date, which could alter the vesting timeline if not met.
• Continued employment is required for the shares to vest, posing a risk to the officer if employment ceases.

Future Outlook

The grant of shares includes a time-based vesting schedule extending over several years, with a potential modification to the schedule if Criteo's conversion into a Luxembourg company is not completed by the first anniversary of the grant date.

Industry Context

StockSavvy.ai notes that equity grants, particularly restricted stock units or similar awards with vesting schedules, are a standard and widely adopted practice in the technology and advertising industries. These grants are designed to incentivize executive performance, foster long-term commitment, and align the interests of key personnel with those of shareholders.

Comparison to Industry Standards

• Equity grants to executive officers are a common compensation mechanism across publicly traded companies, particularly in the technology sector, aligning executive incentives with long-term company performance.
• The multi-year vesting schedule is typical for such grants, promoting executive retention and sustained focus on company growth.

Stakeholder Impact

• Shareholders: The grant aligns the Chief Legal Officer's financial interests with the company's long-term performance, potentially benefiting shareholders.
• Employees (specifically Ryan Damon): Provides a significant long-term incentive and compensation component, enhancing retention.

Next Steps

• Continued employment of Ryan Damon for the shares to vest according to the schedule.
• Monitoring the progress of Criteo's potential conversion into a Luxembourg company, as it impacts the vesting schedule.

Key Dates

Recommendation

The grant of restricted shares to a Chief Legal Officer is a standard compensation practice aimed at retaining key talent and aligning their interests with long-term shareholder value. This event does not provide new information about the company's operational performance or strategic direction that would warrant a change in investment recommendation.

Keywords

Criteo, CRTO, Ryan Damon, Chief Legal Officer, SEC Form 4, Insider Transaction, Stock Grant, Equity Compensation, Vesting, Ordinary Shares, Restricted Stock